Erschienen in:
22.07.2020 | Breast Oncology
Primary Site Surgery and Survival Impact in Metastatic HER2-Amplified Breast Cancer: Responsible use of Cohort Data
verfasst von:
Robert W. Krell, MD, Philip M. Spanheimer, MD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 10/2020
Einloggen, um Zugang zu erhalten
Excerpt
We read with interest the article by Mudgway et al. entitled “The Impact of Primary Tumor Surgery on Survival in HER2 Positive Stage IV Breast Cancer Patients in the Current Era of Targeted Therapy”.
1 With significant advances in systemic therapy for human epidermal growth factor receptor 2 (HER2)-amplified breast cancer, the therapeutic advantage of primary site resection in metastatic disease remains an important and open question. …